We are live on ! Find out more
CBT

Capital Bank & Trust Portfolio holdings

AUM $3.15M
1-Year Est. Return 32.15%
This Fund
S&P 500
This Quarter Est. Return
+3.64%
1 Year Est. Return
+32.15%
3 Year Est. Return
+132.86%
5 Year Est. Return
10 Year Est. Return
AUM
$8.11B
AUM Growth
+$211M
Cap. Flow
-$22.6M
Cap. Flow %
-0.28%
Top 10 Hldgs %
22.7%
Holding
765
New
72
Increased
184
Reduced
146
Closed
81

Top Buys

Rank Stock Value
1
INTC icon
Intel
INTC
+$23.6M
2
XOM icon
ExxonMobil
XOM
+$21.4M
3
NTAP icon
NetApp
NTAP
+$17.8M
4
EQIX icon
Equinix
EQIX
+$17.2M
5
CABO icon
Cable One
CABO
+$16.6M

Top Sells

Rank Stock Value
1
IEX icon
IDEX
IEX
+$44.4M
2
ACN icon
Accenture
ACN
+$26.1M
3
ATVI
Activision Blizzard
ATVI
+$18.4M
4
AES icon
AES
AES
+$18.3M
5
CME icon
CME Group
CME
+$17.1M

Sector Composition

Rank Sector Weight
1 Technology 20.76%
2 Financials 18.17%
3 Industrials 11.72%
4 Healthcare 11.24%
5 Communication Services 8.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRM icon
201
Salesforce
CRM
$152B
$821K 0.01%
5,414
+146
+3% +$22.9K
TLTE icon
202
FlexShares Morningstar Emerging Markets Factor Tilt Index Fund
TLTE
$339M
$775K 0.01%
14,944
GLD icon
203
SPDR Gold Trust
GLD
$131B
$737K 0.01%
5,530
IJH icon
204
iShares Core S&P Mid-Cap ETF
IJH
$124B
$695K 0.01%
17,880
+1,325
+8% +$50.8K
IWD icon
205
iShares Russell 1000 Value ETF
IWD
$82.6B
$692K 0.01%
5,440
IEX icon
206
IDEX
IEX
$17.2B
$690K 0.01%
4,008
-282,620
-99% -$44.4M
TMO icon
207
Thermo Fisher Scientific
TMO
$212B
$683K 0.01%
2,327
+439
+23% +$121K
ICPT
208
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$668K 0.01%
+8,400
New +$752K
EEM icon
209
iShares MSCI Emerging Markets ETF
EEM
$28.9B
$654K 0.01%
15,243
RDS.A
210
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$646K 0.01%
9,929
+1,241
+14% +$79.3K
GUNR icon
211
FlexShares Global Upstream Natural Resources Index Fund
GUNR
$7.17B
$641K 0.01%
19,407
GE icon
212
GE Aerospace
GE
$383B
$631K 0.01%
12,053
+1,356
+13% +$66.7K
CL icon
213
Colgate-Palmolive
CL
$71.6B
$613K 0.01%
8,558
-200
-2% -$14.2K
FMC icon
214
FMC
FMC
$1.3B
$609K 0.01%
7,340
+140
+2% +$11K
IWO icon
215
iShares Russell 2000 Growth ETF
IWO
$14.6B
$607K 0.01%
3,023
MSEX icon
216
Middlesex Water
MSEX
$1.07B
$593K 0.01%
10,000
VMC icon
217
Vulcan Materials
VMC
$36.7B
$588K 0.01%
4,282
GS icon
218
Goldman Sachs
GS
$303B
$579K 0.01%
2,830
+308
+12% +$61K
PLD icon
219
Prologis
PLD
$135B
$577K 0.01%
7,200
+5,500
+324% +$419K
GDX icon
220
VanEck Gold Miners ETF
GDX
$23.2B
$571K 0.01%
22,340
SIVR icon
221
abrdn Physical Silver Shares ETF
SIVR
$4.03B
$561K 0.01%
37,760
NOAH
222
Noah Holdings
NOAH
$584M
$551K 0.01%
12,956
IWR icon
223
iShares Russell Mid-Cap ETF
IWR
$56.3B
$539K 0.01%
9,654
+5,450
+130% +$299K
NCLH icon
224
Norwegian Cruise Line
NCLH
$9.07B
$538K 0.01%
10,038
PPLT
225
abrdn Physical Platinum Shares ETF
PPLT
$1.88B
$524K 0.01%
66,400

Similar funds

Capital Bank & Trust's Q2 2019 Portfolio in Review

As of Q2 2019, Capital Bank & Trust held 765 positions worth $8.11B, up 2.7% from $7.9B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Capital Bank & Trust's Q2 2019 filing shows 72 new, 184 increased, 146 reduced and 81 closed positions. Its largest new stake was SI-BONE Inc: 258,056 shares worth $5.25M. The largest sale was IDEX, an estimated $44.4M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Financials and Industrials.

  • Capital Bank & Trust's largest Q2 2019 buy was SI-BONE Inc: 258,056 shares worth $5.25M.
  • Capital Bank & Trust added most to Intel in Q2 2019, an estimated $23.6M increase.
  • Capital Bank & Trust's biggest Q2 2019 reduction was IDEX, cutting an estimated $44.4M.
  • Capital Bank & Trust fully exited JP Morgan Alerian MLP Index ETN 5/24/24 in Q2 2019, selling an estimated $1.05M.
  • Capital Bank & Trust's ten largest holdings make up 23% of its $8.11B portfolio in Q2 2019.
  • Capital Bank & Trust opened 72 new positions and closed 81 in Q2 2019.
  • Capital Bank & Trust's portfolio value rose 2.7% quarter-over-quarter to $8.11B.

Based on Capital Bank & Trust's 13F filing for Q2 2019, filed 14 Aug 2019.